BellRock Brands Expands its Product Portfolio in Michigan and Announces Licensing Partnership to Enter the Ohio Market
April 27th, 2022
News, Top News
Cannabis Multi-State House of Brands Executes Upon Growth Strategy in New and Existing Markets
DENVER, April 27, 2022 /CNW/ – BellRock Brands Inc. (“BellRock” or the “Company”) (CSE: BRCK.U), an industry-leading cannabis multi-state house of brands (“MSHB”), today announced that the Company has expanded its presence in Michigan with the introduction of two new Dixie Elixirs flavors and will enter the Ohio market though a licensing partnership with BeneLeaves, one of Ohio’s leading cannabis processors. Both moves exemplify BellRock’s focus on driving organic growth of existing brands and expanding its reach through new markets. The addition of the Ohio market brings BellRock’s North American footprint to 10 U.S. THC markets and Canada.
Mary’s Medicinals, BellRock’s cannabis wellness brand, will be the first to be manufactured and distributed in Ohio, and the Company has plans to expand the BeneLeaves partnership to include other brands within the BellRock portfolio in the future. The Company anticipates that Mary’s acclaimed products, including its patches, topicals and tinctures, will be available through BeneLeaves later this year.
BellRock CEO Brian Jansen said, “I have known the BeneLeaves team for three years and have always been impressed with their level of commitment to Ohio’s patients and customers. We are excited to enter the Ohio market with a partner that shares our core values. BeneLeaves’ production facility is one of the best in the country. Their team is committed to expanding access to patients and delivering high quality cannabis products.”
“We are very excited to roll out the complete line of industry leading brands in the BellRock portfolio. Brian and the BellRock team have built an amazing following, and we are so proud to bring these trusted, high-quality products to the patients of Ohio,” said Bill Williams, President and CEO of BeneLeaves.
BellRock’s focus on the Ohio market coincides with the Company’s expanded brand presence in Michigan. Next month, Dixie Brands, in collaboration with its partner, JRMI27, LLC, will add two additional Dixie Elixirs beverage flavors. Dixie Elixirs are the first 100 mg beverage products to launch in Michigan.
“Increasing the Dixie Elixirs beverage portfolio in Michigan is an important milestone for BellRock,” said Jansen. “We are pleased to work with JRMI27 to pave the way for new delivery methods in the state, and plan to continue delighting consumers with innovative form factors and high-quality cannabis products.”
Looking ahead, BellRock will continue to pursue growth in its existing markets through product innovation and the expansion of its entire product offering. The Company will continue to enter new markets through both strategic partnerships and license acquisitions.
Additionally, BellRock has been thoroughly re-assessing all of the Company’s relationships as it drives towards free cashflow positive. As part of this strategic evaluation, it has been decided that the previously announced agreement between AriZona Tea and Dixie Brands to launch Sun Brew THC gummies has been terminated.
ABOUT BELLROCK BRANDS:
BellRock Brands is a cannabis multi-state house of brands and intellectual property focused CPG operator that possesses one of the industry’s broadest branded product portfolios. BellRock consists of two iconic cannabis brands, Mary’s Medicinals (a pioneer in the Health & Wellness segment since 2013) and Dixie (a market-leading cannabis-infused edibles brand since 2010). BellRock also includes two growing California-based brands, Rebel Coast and Défoncé. BellRock’s CBD portfolio includes the brands Mary’s Nutritionals and Mary’s Tails. With 7 brands and over 200 SKUs, BellRock reaches nearly every key consumer group and addresses the needs of a diverse cannabis consumer base. The BellRock manufacturing and distribution footprint continues to expand and currently spans nine states, and the Company owns or manages production facilities in its largest markets. For more information, visit www.bellrockbrands.com.
BeneLeaves is a family, minority, and women owned medical cannabis processor based in Columbus, Ohio. BeneLeaves creates deep connections with its patients, inspiring them towards new levels of wellness and happiness. We are patient focused and Ohio proud.
We are rapidly rising and taking the cannabis industry to the next level with our personal innovations and expertise. We focus on quality efficiency and most importantly the patients of Ohio. We’ve built our business from the ground up both structurally and operationally with much success due to generations of past business experience. BeneLeaves produces infused vape pens, lotions, capsules, gummies, chocolate bars, and gluten and sugar free cookies.
For more information, visit beneleaves.com and follow our social media handle: @BeneLeaves.
Here is a brief video we created to help share our facility and capabilities:
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.